Hair clogs are one of the most common household problems, but chemical drain cleaners often cause more damage than they solve ...

NEW YORK, NY / ACCESS Newswire / December 12, 2025 / Industries rarely adopt new technology in a straight line. The process unfolds in stages that are predictable to insiders but invisible to the ...

John Eimen, a former child star known for his guest spot in "Leave it to Beaver," died Friday, Nov. 21, a representative confirmed. He was 76. Eimen died at his home in Mukilteo, Washington, from ...

When "Dilbert" creator Scott Adams recently made a public plea for help accessing a life-extending cancer treatment, the story drew national attention — and sparked some questions about the drug ...

Elon Musk is back on his rambling about the Tesla Roadster being able to “fly” and claims a demo is coming by the end of the year. But we’ve heard it before… Tesla CEO Elon Musk went on Joe Rogan’s ...

Approaches to early detection of cancer often seem contentious, but the big-picture view is actually one of remarkable consensus. All major guideline groups recommend the Papanicolaou smear, ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer. Adding the drug enzalutamide to standard hormone therapy reduced the risk of ...

People with diabetes may experience changes in their urinary and digestive health, and research shows there may be different effects on the body impacting the development of prostate cancer. Diabetes ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay disease progression in men with specific DNA repair gene mutations. In the ...

Ed O'Keefe is CBS News' senior White House and political correspondent reporting for all CBS News platforms. He's part of the team covering President Trump and covered all four years of Joe Biden's ...

177Lu-PSMA-617 combined with ADT and ARPI reduced progression or death risk by 28% in PSMA-positive mHSPC patients. The PSMAddition trial showed significant rPFS improvement and a positive OS trend, ...